ArticleScientific reports2026
Association of platelet to HDL-C ratio with short-term mortality in critically ill intracerebral hemorrhage patients: a MIMIC-IV analysis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association between platelet/high-density lipoprotein cholesterol ratio and incidence of coronary heart disease: insights from the UK Biobank.BMC cardiovascular disorders · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intracerebral hemorrhage (ICH) is associated with substantial early mortality, yet prognostic biomarkers integrating coagulation, inflammation, and lipid metabolism are limited. The platelet to high-density lipoprotein cholesterol ratio (PHR) may reflect this balance. In a retrospective cohort of 878 critically ill ICH patients from the MIMIC-IV database (mean age 69.6 ± 13.8 years, 55.0% female), overall in-hospital and 30-day mortality were 15.0% and 20.5%, respectively. Short-term mortality was defined as death occurring either during hospitalization (in-hospital mortality) or within 30 days of admission (30-day mortality). Higher PHR at ICU admission was independently associated with lower short-term mortality. Each 1-SD increase corresponded to a 20–28% reduction in risk for in-hospital (adjusted HR 0.72, 95% CI 0.59–0.87) and 30-day mortality (HR 0.80, 95% CI 0.68–0.94). When analyzed by quartiles, patients in the highest PHR group had the lowest mortality (in-hospital HR 0.49, 95% CI 0.29–0.83; 30-day HR 0.55, 95% CI 0.35–0.88), consistent with Kaplan-Meier survival analyses. Restricted cubic spline analysis indicated a linear inverse relationship. Results were robust in subgroup analyses and largely consistent in sensitivity analyses, with modest attenuation for in-hospital mortality. These findings suggest PHR has an independent inverse relationship with short-term mortality. Important prognostic factors, including hematoma volume and location, were unavailable; PHR may reflect underlying disease severity rather than causal protection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.